Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Nice 50,000 Share Buy !!!
John Dvor EVP North America at Pluri Biotech Ltd
https://pluri-biotech.com/our-story-team/
UK mulls rule changes to allow faster cultivated meat and animal-free dairy approvals[/b
https://www.foodnavigator.com/Article/2023/06/09/uk-mulls-rule-changes-to-allow-faster-cultivated-meat-and-animal-free-dairy-approvals
Placental Stem Cell Therapy Market to reach US$ 4.4 billion in 2030, expanding at a CAGR of 20%:
https://finance.yahoo.com/news/placental-stem-cell-therapy-market-113300751.html
Tweedy Tweet Treat !!!
https://twitter.com/Pluribiotech
GIDDY-UP !!!
Enhancement of viral transduction efficiency for autologous cell therapy to treat rare diseases
WOW !!! JUNE 19TH IN LONDON PLURI GENE THERAPY !!!
9:00 AM EST PROGRESSING THE THERAPEUTIC POTENTIAL OF MESENCHYMAL-LIKE ADHERENT STROMAL CELLS AS EFFECTIVE CELL THERAPIES
Lior Raviv, CTO, Pluri Biotech
Applications for stromal cell derived regenerative medicines in mainstream medicine
Enhancement of viral transduction efficiency for autologous cell therapy to treat rare diseases
Applying Pluri Biotech's 3D manufacturing platform for cell therapies
https://www.smgconferences.com/pharmaceuticals/uk/conference/cell-gene-therapy#tab_programme
[b[color=red]]Tweedy Tweet Tweet[/color]
https://twitter.com/Pluribiotech
You Have Much To Learn...Observe !!!
Bear Raid Underway !!! Big News Coming !!! They Want To Buy Cheaper Shares !!! GIDDY-UP !!!
December 2022 Buyers Just Registered Their Shares/Warrants !!! News Coming Soon ???
The Common Shares being offered by the selling shareholders listed below (or their successors and assigns) were issued pursuant to a private placement transaction. Between December 13, 2022 and December 27, 2022, we entered into a series of securities purchase agreements with several purchasers for an aggregate of 8,155,900
https://www.sec.gov/Archives/edgar/data/1158780/000121390023044999/ea179543-s3_pluriinc.htm
To The Moon....In June !!!
You Never Will Have A Clue !!! LOVE IT !!!
Another Big Call Buy Today !!!
https://fintel.io/so/us/psti
BIG CALL BUY !!!
https://fintel.io/so/us/psti
The Shorts Had To Cover 117K Shares Before The Big News In June !!! GIDDY-UP !!!
https://www.nasdaq.com/market-activity/stocks/plur/short-interest
IMO...Anyone Who Owns PLURI...Will Never Worry !!!
Tutes Know......It's Pure Gold !!!
https://tvtropes.org/pmwiki/pmwiki.php/Main/SolidGoldPoop
Pluri May Presentation Is Out !!!
https://pluri-biotech.com/presentation/
Everything Passed At The Shareholders Meeting !!! GIDDY-UP !!!
https://www.sec.gov/ix?doc=/Archives/edgar/data/1158780/000121390023033258/ea177589-8k_pluriinc.htm
Mesenchymal Stem/stromal Cells (MSCs) or exosomes for disease or injury modification
There is discussion in the stem cell field about what product will be best for treating different disease indications- MSCs or their exosomes? There are pros and cons to each product, and one might be better than the other for the treatment of specific diseases or tissue injuries. For instance, exosomes might replace the functions of IV-administered MSCs for treating Graft vs. Host disease or for other immunomodulatory functions, whereas for tissue or bone repair MSCs injected locally and engineered to be retained for longer periods of time might be best, to orchestrate healing.
https://academic.oup.com/stmcls/pages/call-for-papers?login=false
It Looks Like AstraZenca Has Taken A Keen Interest In Mesenchymal Stromal Cells !!!
I Wonder If Pluri Has Found A Dance Partner ???
The critical role of apoptosis in mesenchymal stromal cell therapeutics and implications in homeostasis and normal tissue repair
https://www.nature.com/articles/s41423-023-01018-9
Cell Manufacturing Pioneer, Pluri Inc., Unveils PluriMatrix: a Breakthrough System for Unprecedented Industrial Scale Production of Cell-Based Products
https://pluri-biotech.com/wp-content/uploads/2023/04/Pluri_Unveils_PluriMatrix_PR_FINAL_FOR_RELEASE_isa.pdf
And They Are Beautifully Indicative Of What's To Come !!!
https://commons.wikimedia.org/wiki/File:Golden_Cricket_-_Flickr_-_treegrow_%283%29.jpg
Good Insights !!!
Conclusion:
The horizon for the use of next generation engineered MSCs appears bright with both genetic and non-genetic engineering strategies emerging. Together with quantitative approaches to fully and carefully characterize MSC potency attributes, the editors of this series are optimistic that the next generation MSCs will be more efficacious in clinical trial outcomes and bridge the gap to clinical and commercial success.
https://www.frontiersin.org/articles/10.3389/fimmu.2023.1192636/full
A Nation Making Amends
https://www.jpost.com/diaspora/article-739648